News
-
-
-
PRESS RELEASE
Kidoz Inc. : 2024 Record Adjusted EBITDA of USD $1,134,503 (CAD $1,554,963) and Revenue of USD $14,004,527 (CAD $19,194,773)
Kidoz Inc. announces audited financial results for 2024, showcasing increased revenue and net income. CEO Jason Williams highlights importance of privacy-first technology in driving growth -
PRESS RELEASE
Onco-Innovations' Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science
Onco-Innovations Limited's subsidiary, Inka Health Corp., partners with AstraZeneca Canada for real-world evidence research in oncology. The new engagement showcases Inka Health's expertise in evidence translation and market access -
-
PRESS RELEASE
Cumulative sales of EUR 20.9m in Q3 2025 ( EUR 25.0m on a fully integrated basis), Q3 2025 revenues up 21% vs Q2 2025, Positive contribution from the new acquisition in Norway
La Française de l'Énergie achieves €20.9m sales in first 9 months of FY 2025, with growth from new installations and gas business. Acquisition of Alltec positively impacting revenues. Future targets and projects in Norway contributing to sustainable growth -
PRESS RELEASE
Southern ITS International, Inc., DBA CorpHQ; Announces the Appointment of Gil Irey as President and Tim Guenther as Chief Strategy Officer
Southern ITS International, Inc. appoints Gil Irey as President and Tim Guenther as Chief Strategy Officer. Irey brings healthcare expertise, and Guenther focuses on growth and profitability -
PRESS RELEASE
EQS-Adhoc: Merck KGaA: Merck confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition
Merck KGaA confirms late-stage discussions with SpringWorks Therapeutics, Inc. on potential acquisition, at around USD 47 per share. No final decision or binding agreement yet -
-
